J-f Emile

9, Avenue Charles De Gaulle
Boulogne-billancourt, 92100, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-programmed-death-receptor-1 monoclonal antibodies.

Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-programmed-death-receptor-1 monoclonal antibodies.

Journal: The British journal of dermatology

Published: July 30, 2020

Corrigendum to 'Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study': Annals of Oncology 2020; Volume 31: 921-929.

Corrigendum to 'Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study': Annals of Oncology 2020; Volume 31: 921-929.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 13, 2020

Loss of SMARCB1 expression in colon carcinoma.

Loss of SMARCB1 expression in colon carcinoma.

Journal: Cancer biomarkers : section A of Disease markers

Published: February 22, 2020

Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study.

Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 17, 2020

A tularemia mimicking lymphoma

A tularemia mimicking lymphoma

Journal: La Revue de medecine interne

Published: December 14, 2019

Use of targeting therapy in Erdheim-Chester disease: A case report with neurologic involvement

Use of targeting therapy in Erdheim-Chester disease: A case report with neurologic involvement

Journal: La Revue de medecine interne

Published: June 17, 2019

Sarcoidosis occurring during BRAF/MEK inhibitors is associated with paradoxical ERK activation in Erdheim-Chester patients.

Sarcoidosis occurring during BRAF/MEK inhibitors is associated with paradoxical ERK activation in Erdheim-Chester patients.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 20, 2019

Progress towards molecular-based management of childhood Langerhans cell histiocytosis.

Progress towards molecular-based management of childhood Langerhans cell histiocytosis.

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Published: October 30, 2018

A case of Erdheim-Chester disease with spinal cord compression and sphenoid sinus involvement.

A case of Erdheim-Chester disease with spinal cord compression and sphenoid sinus involvement.

Journal: Neuro-Chirurgie

Published: November 13, 2017

Rosai-Dorfman disease: Diagnosis and therapeutic challenges

Rosai-Dorfman disease: Diagnosis and therapeutic challenges

Journal: La Revue de medecine interne

Published: October 29, 2017

FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study.

FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study.

Journal: Blood

Published: February 03, 2017

Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.

Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 22, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026